These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 10845767)
21. Update on oral treatments for male erectile dysfunction. Kalsi JS; Kell PD J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134 [TBL] [Abstract][Full Text] [Related]
22. [Current role of intracavernous therapy in the treatment of erectile dysfunction]. Asuar Aydillo S Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413 [No Abstract] [Full Text] [Related]
24. [Assessment of curative effect on erectile dysfunction of two drugs]. Yang DZ; Ma XN; Yu ZJ; Jiao Y Zhonghua Nan Ke Xue; 2003; 9(4):260-2. PubMed ID: 12931365 [TBL] [Abstract][Full Text] [Related]
25. Yohimbine enhances the effect of sildenafil on erectile process in rats. Senbel AM; Mostafa T Int J Impot Res; 2008; 20(4):409-17. PubMed ID: 18418393 [TBL] [Abstract][Full Text] [Related]
26. Effects of alpha-2 blockade on sexual response: experimental studies with delequamine (RS15385). Bancroft J Int J Impot Res; 2000 Mar; 12 Suppl 1():S64-69. PubMed ID: 10845766 [TBL] [Abstract][Full Text] [Related]
27. Nutrients and botanicals for erectile dysfunction: examining the evidence. McKay D Altern Med Rev; 2004 Mar; 9(1):4-16. PubMed ID: 15005641 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacotherapy for erectile dysfunction]. Hu WL; Hu LQ Zhonghua Nan Ke Xue; 2005 Aug; 11(8):626-30. PubMed ID: 16138587 [TBL] [Abstract][Full Text] [Related]
30. Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction. Padma-Nathan H; Goldstein I; Klimberg I; Coogan C; Auerbach S; Lammers P; Int J Impot Res; 2002 Aug; 14(4):266-70. PubMed ID: 12152116 [TBL] [Abstract][Full Text] [Related]
31. Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Vogt HJ; Brandl P; Kockott G; Schmitz JR; Wiegand MH; Schadrack J; Gierend M Int J Impot Res; 1997 Sep; 9(3):155-61. PubMed ID: 9315493 [TBL] [Abstract][Full Text] [Related]
34. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials. Blonde L Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971 [TBL] [Abstract][Full Text] [Related]
35. [Yohimbine in the treatment of erectile dysfunction]. Pushkar' DIu; Segal AS; Bagaev AG; Nosovitskiĭ PB Urologiia; 2002; (6):34-7. PubMed ID: 12577576 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic effects of high dose yohimbine hydrochloride on organic erectile dysfunction. Telöken C; Rhoden EL; Sogari P; Dambros M; Souto CA J Urol; 1998 Jan; 159(1):122-4. PubMed ID: 9400452 [TBL] [Abstract][Full Text] [Related]
37. Apomorphine SL (Uprima): preclinical and clinical experiences learned from the first central nervous system-acting ED drug. Giuliano F; Allard J Int J Impot Res; 2002 Feb; 14 Suppl 1():S53-6. PubMed ID: 11850736 [TBL] [Abstract][Full Text] [Related]
39. Central nervous system agents in the treatment of erectile dysfunction. Kendirci M; Walls MM; Hellstrom WJ Urol Clin North Am; 2005 Nov; 32(4):487-501, vii. PubMed ID: 16291040 [TBL] [Abstract][Full Text] [Related]
40. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction. Bratus D; Hlebic G; Hajdinjak T Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]